Fig 1.
A schematic-diagram illustrating the production, characterisation, and applications of MgO-NPs synthesized by WP extract.
Fig 2.
3D crystallography of the DHFR enzyme obtained from protein data bank.
Fig 3.
UV-vis spectrum of biosynthesis MgONPs.
Fig 4.
FT-IR spectra of biosynthesized MgONPs.
Fig 5.
XRD analysis of biosynthesized MgONPs.
Fig 6.
TEM image of the biosynthesized MgONPs.
Fig 7.
Antimicrobial properties of MgONPs versus different microbial strains.
Fig 8.
Antibiofilm activity of biosynthesized MgONPs toward MRSA at varying doses.
Fig 9.
Light-inverted microscopy pictures of S. aureus biofilms cultivated in different MgONPs doses.
Fig 10.
Structural interaction of MgO-NPs within the active site of dihydrofolate reductase (DHFR) (PDB ID: 2W9H).
(A & B) 3D representations showing the binding mode of MgO-NPs within the DHFR active site, highlighting interactions with surrounding amino acid residues. (C) 2D interaction diagram illustrating the binding of MgO-NPs within the active pocket and their interactions with key amino acids.
Fig 11.
Antioxidant capability of biosynthesized MgONPs at varies concentrations.
Fig 12.
Antiviral efficacy of bioـsynthesized MgONPs against HAV.
Fig 13.
Antiviral efficacy of bioـsynthesized MgONPs against HSV1.